Browsing by Yonsei Author : Park, Kyungsoo

eperson profile image
Name:
Park, Kyungsoo [박경수]
orcid http://orcid.org/0000-0002-6972-1143
Department :
College of Medicine (의과대학) - Dept. of Pharmacology (약리학교실)
Scopus ID :
Scopus (55722198500)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 59

This table browses all dspace content
Issue DateTitleJournal Title
2023Model-informed precision dosing in vancomycin treatment FRONTIERS IN PHARMACOLOGY
2023Development of a population pharmacokinetic model and optimal dosing regimen of leflunomide in Korean population EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
2022Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers DRUG DESIGN DEVELOPMENT AND THERAPY
2022A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer PHARMACEUTICS
2022The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
2021Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers JOURNAL OF PERSONALIZED MEDICINE
2021Predicting the longitudinal changes of levodopa dose requirements in Parkinson's disease using item response theory assessment of real-world Unified Parkinson's Disease Rating Scale CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
2021Population Pharmacokinetics of Primaquine in the Korean Population PHARMACEUTICS
2021Development of a risk scoring system for predicting acute kidney injury after minimally invasive partial and radical nephrectomy: a retrospective studySURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
2020Chemical Controllable Gene Drive in DrosophilaACS SYNTHETIC BIOLOGY
2020Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects MOLECULAR GENETICS & GENOMIC MEDICINE
2020Dynamic predictive model for postoperative nausea and vomiting for intravenous fentanyl patient-controlled analgesiaANAESTHESIA
2019Predicting Disease Progression in Patients with Bicuspid Aortic Stenosis Using Mathematical Modeling Journal of Clinical Medicine
2019Optimal Dosing Regimen of Phenytoin for Korean Epilepsy Patients: From Premature Babies to the ElderlyJournal of Pharmaceutical Sciences
2018Population pharmacokinetic model of levetiracetam in Korean neonates with seizuresINTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2018Population PK-PD Model of Pegylated Interferon Alfa-2a in Healthy Korean MenJOURNAL OF PHARMACEUTICAL SCIENCES
2018Model-based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic strokeBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2018A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and ChemotherapyAAPS JOURNAL
2018An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patientsJOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
2018Mechanistic Model for Blood Pressure and Heart Rate Changes Produced by Telmisartan in Human BeingsBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
2017Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures Korean Journal of Pediatrics
2017A Review of Modeling Approaches to Predict Drug Response in Clinical Oncology YONSEI MEDICAL JOURNAL
2017Quantitative Assessment of Food Effect on the Pharmacokinetics of Nano-Crystallized Megestrol AcetateBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
2016Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipineBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2016Pore dilatation increases the bicarbonate permeability of CFTR, ANO1 and glycine receptor anion channels.JOURNAL OF PHYSIOLOGY-LONDON
2016Modelling of the Effect of End-Tidal Carbon Dioxide on Cerebral Oxygen Saturation in Beach Chair Position under General Anaesthesia.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
2015Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjectsINTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2014Population pharmacokinetic analysis of diurnal and seasonal variations of plasma concentrations of cilostazol in healthy volunteers. THERAPEUTIC DRUG MONITORING
2014Pharmacokinetic Interaction Between Rosuvastatin and Metformin in Healthy Korean Male Volunteers: A Randomized, Open-label, 3-period, Crossover, Multiple-dose StudyCLINICAL THERAPEUTICS
2014Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan: A Randomized, Open-label, 3-period, Multiple-dose Crossover Study in Healthy Korean Male SubjectsCLINICAL THERAPEUTICS
2014Pharmacokinetic Interaction between Rosuvastatin and Telmisartan in Healthy Korean Male Volunteers: A Randomized, Open-label, Two-period, Crossover, Multiple-dose StudyCLINICAL THERAPEUTICS
2014Development of a Pharmacokinetic Interaction Model for Co-administration of Simvastatin and Amlodipine DRUG METABOLISM AND PHARMACOKINETICS
2013Pharmacokinetic Comparison of 2 Fixed-Dose Combination Tablets of Amlodipine and Valsartan in Healthy Male Korean Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover StudyCLINICAL THERAPEUTICS
2013Pharmacokinetics of Rosuvastatin/Olmesartan Fixed-Dose Combination: A Single-Dose, Randomized, Open-Label, 2-Period Crossover Study in Healthy Korean SubjectsCLINICAL THERAPEUTICS
2013Pharmacokinetic Comparison of an Orally Disintegrating Film Formulation With a Film-Coated Tablet Formulation of Sildenafil in Healthy Korean Subjects: A Randomized, Open-Label, Single-Dose, 2-Period Crossover StudyCLINICAL THERAPEUTICS
2012The UGT1A3*2 polymorphism affects atorvastatin lactonization and lipid-lowering effect in healthy volunteersPHARMACOGENETICS AND GENOMICS
2012A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.INVESTIGATIONAL NEW DRUGS
2012Modeling of the LDL cholesterol-lowering effect of atorvastatin in Korean dyslipidemic patients and non-patient volunteers.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2012The views of patients and healthy volunteers on participation in clinical trials: an exploratory survey study.CONTEMPORARY CLINICAL TRIALS
2012Role of heat shock protein 47 in transdifferentiation of human tenon's fibroblasts to myofibroblasts. BMC OPHTHALMOLOGY
2011Pharmacokinetic comparison of sustained- and immediate-release oral formulations of cilostazol in healthy Korean subjects: a randomized, open-label, 3-part, sequential, 2-period, crossover, single-dose, food-effect, and multiple-dose studyCLINICAL THERAPEUTICS
2011The T2-shortening effect of gadolinium and the optimal conditions for maximizing the CNR for evaluating the biliary system: a phantom study. KOREAN JOURNAL OF RADIOLOGY
2011Population pharmacokinetics of amikacin in a Korean clinical populationINTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2011The effect of beta1-adrenergic receptor gene polymorphism on prolongation of corrected QT interval during endotracheal intubation under sevoflurane anesthesia KOREAN JOURNAL OF ANESTHESIOLOGY
2011Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participantsCLINICAL PHARMACOLOGY & THERAPEUTICS
2011Effect of CYP2B6 genotype on the pharmacokinetics of sibutramine and active metabolites in healthy subjectsJOURNAL OF CLINICAL PHARMACOLOGY
2010PEG-인터페론 알파-2a 제제 DA-3021의 안전성 및 약동력학적 특성 연구 Journal of Korean Society for Clinical Pharmacology and Therapeutics (임상약리학회지)
2010Prognostic factors in small cell lung cancer: a new prognostic index in Korean patientsONCOLOGY
2010Modeling the effect of sevoflurane on corrected QT prolongation: a pharmacodynamic analysis ANESTHESIOLOGY
2010A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancerINVESTIGATIONAL NEW DRUGS
12

Browse

Links